As it turns out AI is hardly artificial anymore (slaps knee). The hardest part is making an intelligent decision about what to do with it (slaps knee again, we could do this all day). We’ve employed our own personal Skynet, Sophie Vandebroek and Rudina Seseri, to help us understand and break down this both very new and very old cutting edge idea, and where it may take us. Impending robot apocalypse? Yes, well I understand your view on this
OPERATOR Sophie Vandebroek | COO, IBM Research
Dr. Sophie Vandebroek
COO, IBM Research
Dr. Sophie V. Vandebroek is the Chief Operating Officer of IBM Research. With more than 3,000 researchers in 13 labs located across six continents, IBM Research is one of the world’s largest and most influential corporate research labs. IBM Research is pioneering the most promising and disruptive technologies that will transform industries and society, including the future of AI, blockchain and quantum computing.
Dr. Vandebroek is a Fellow of the Institute of Electrical & Electronics Engineers and holds 14 US patents. She also serves on the Board of Directors of IDEXX Corporation, and on the Dean's Advisory Council of the Massachusetts Institute of Technology School of Engineering. She has a Masters Degree in Engineering from KU Leuven, Belgium and a PhD in Engineering from Cornell University.
INVESTOR Rudina Seseri | Founder & GP, Glasswing Ventures
Founder, Glasswing Ventures
Rudina Seseri is Founder and Managing Partner of Glasswing Ventures, an early-stage venture capital firm dedicated to investing in the next generation of AI-powered technology companies. With over 16 years of investing and transactional experience, Rudina has led technology investments and acquisitions in startup companies in enterprise SaaS, IT software and data, marketing technologies and robotics. Rudina’s portfolio of investments include Celtra, CrowdTwist, Inrupt, Jibo, SocialFlow and Talla. Rudina served as Entrepreneur-In-Residence for the Harvard Business School for 4 consecutive years and has most recently been named to the 2018 HBS inaugural group of Rock Venture Capital Partners. She is also a Member of the Business Leadership Council of Wellesley College.
Rudina serves as Advisor for GSK Consumer, L’Oreal USA Women in Digital, and on the Philanthropy Board for Boston Children’s Hospital. She has been named a 2017 Boston Business Journal Power 50: Newsmaker, a 2014 Women to Watch honoree by Mass High Tech and a 2011 Boston Business Journal 40-under-40 honoree for her professional accomplishments and community involvement. She graduated magna cum laude from Wellesley College with a BA in Economics and International Relations and with an MBA from the Harvard Business School (HBS). She is a member of Phi Beta Kappa and Omicron Delta Epsilon honor societies.
Stay tuned, a full web transcript is on it's way!